Ikarian Capital, LLC Bio N Tech Se Transaction History
Ikarian Capital, LLC
- $640 Million
- Q3 2025
A detailed history of Ikarian Capital, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Ikarian Capital, LLC holds 319,900 shares of BNTX stock, worth $33 Million. This represents 1.15% of its overall portfolio holdings.
Number of Shares
319,900Holding current value
$33 Million% of portfolio
1.15%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BNTX
# of Institutions
316Shares Held
43.7MCall Options Held
1.15MPut Options Held
1.36M-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.83MShares$498 Million0.29% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$436 Million1.69% of portfolio
-
Primecap Management CO Pasadena, CA3.87MShares$399 Million0.3% of portfolio
-
Dodge & Cox San Francisco, CA3.65MShares$376 Million0.21% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$195 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...